Reasons why patients accept or decline gastrointestinal cancer clinical trials

Cyper Allan, a research nurse of the University of Sheffield, UK, discusses a patient survey regarding gastrointestinal (GI) cancer clinical trials. In November 2015 the gastrointestinal and pelvic team sent out a survey to all clinical research patients within the department. The aim was to determine patient’s perspective on all the clinical trials that were being implemented. It is a very limited survey, which lasted for a very short period of time (3 months). The initial target was the clinic’s own patients, which returned a high response rate of round 60-65%. Around 50% of patients were accepting clinical trials due to trusting their doctor, the rest amounted to altruism and benefits to others as well. Recorded at the 2016 Annual Meeting of the Oncology Nursing Society (ONS), held in Brighton, UK.
Share this video